Survival of patients with deficient mismatch repair metastatic colorectal cancer in the pre-immunotherapy era
Wensink, G.E., Elferink, M.A.G., May, A.M. et al. Survival of patients with deficient mismatch repair metastatic colorectal cancer in the pre-immunotherapy era. Br J Cancer 124, 399–406 (2021). https://doi.org/10.1038/s41416-020-01076-0
Using material from the Netherlands Cancer Registry the authors present survival data for metastatic colon cancer patients who have mismatch repair deficient tumours.
Read the Abstract here.
HTL (ASCP), G. Manager of ABiTi Consultancy Services (ACS); Certified by American Society for Clinical Pathologists (ASCP) USA; Member of National Society for Histotechnologists (NSH), USA * Ambassador of ASCP
4 年Thank you John Garratt; for your contribution as cancer nowadays the leading cause of death!!